CD8A and neoplasm: In-depth functional and phenotypic analysis of the abundant immune populations (e.g., cytotoxic CD8+ T cells [34] and tumor-associated macrophages [35, 36]) at the tumor invasive front of OSCC can help identify how immune presence influences the response to immunotherapies [37, 38].